Diabetic dyslipidaemia and coronary heart disease: New perspectives

Current Opinion in Lipidology

Volumn 10, Issue 5, 1999, Pages 387-391

  Evans, Marc ^a   Khan, Niaz ^a   Rees, Alan ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; HUMANS; HYPERLIPIDEMIAS; OXIDATIVE STRESS; POSTPRANDIAL PERIOD;

EID: 0033384740     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199910000-00002     Document Type: Review

References (58)

1. 1 Lakkso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998; 137 (Suppl):S65-S73. This review article focuses on macrovascular disease namely coronary heart disease, stroke and peripheral vascular disease in non-insulin dependent diabetes mellitus and impaired glucose tolerance. A variety of cardiovascular risk factors tend to co-segregate in these patients. This article discusses in detail the role of various cardiovascular risk factors in predicting vascular disease in both non-insulin dependent diabetes mellitus and impaired glucose tolerance.
2. 2 Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America. 2nd ed. NIH publication 95-1468. Harris MI (editor). Bethesda MD: National Institutes of Health. National Institutes of Diabetes and Digestive and Kidney Disease; 1995. pp. 429-448.
3. 3 Currie CJ, Morgan CLI, Peters JR. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 1997; 78:544-549.
4. 4 Stray HC. Evolution and progression of atherosclerotic lesions in coronary arteries in children and young adults. Atherosclerosis 1989; 99 (Suppl 1): I19-I32.
5. 5 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
6. 6 Henderson A. Endothelium in control. Br Heart J 1991; 65:116-125.
7. 7 Celermajer D, Sorensen K, Gooch V, Speighalter D, Deanfield J. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
8. 8 Goodfellow J, Ramsey M, Luddington LA, Jones CJ, Coates PA, Dunstan F, et al. BMJ 1996; 312:744-745.
9. 9 Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350 (Suppl 1):SI9-SI13.
10. 10 Reaven GM, Greenfield HS. Diabetic hypertriglyceridaemia. Evidence for three clinical syndromes. Diabetes 1981; 30 (Suppl 2):66-75.
11. 11 Malmstrom R, Packard CJ, Caslake M, Bedford D, Stewart P, Yheri-Jaronian H. Defective metabolism of triglyceride metabolism by insulin in the liver in non-insulin dependent diabetes mellitus. Diabetologia 1997; 40:454-462.
12. 12 Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D. The response of plasma triglyceride, cholesterol and lipoprotein lipase to treatment in non-insulin dependent diabetic subjects without familial hypertriglyceridaemia. Diabetes 1983; 32:525-531.
13. 13 Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95:158-166.
14. 14 Deman FHA, Castro Cabezas M, Van Barlingen HHJ, Erkelens DW, De Bruin TWA. Triglyceride rich lipoproteins in non-insulin dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 1996; 26:89-108.
15. 15 Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR. Persistent abnormalities in lipoprotein composition in non-insulin dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990; 10:232-239.
16. 16 Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bierman EL. Abnormal composition of high-density lipoproteins in non-insulin dependent diabetics. Diabetes 1982; 31:126-131.
17. 17 Elckeby M, Prokhov B, Pulcini T, Berthezene F, Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesterol ester transfer in non-insulin dependent diabetes mellitus. Atherosclerosis 1996; 123:93-101.
18. 18 Taskinen MR, Lahdenpera S, Syvanne M. New insights into lipid metabolism in non-insulin dependent diabetes mellitus. Ann Med 1996; 28:335-340.
19. 19 Syvanne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin dependent diabetes mellitus. Lancet 1997; 350 (Suppl 1):20-23.
20. 20 Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclass patterns and the risk of myocardial infarction. JAMA 1998; 260:1917-1921.
21. 21 Sattar N, Petrie JR, Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis 1998; 138:229-235. There is increasing evidence that plasma triglyceride and in particular TGRL are independent coronary heart disease risk factors. The pathogenic links between coronary heart disease and plasma triglyceride are however uncertain. This article discusses some of the mechanisms by which TGRL and free fatty acids may cause endothelial dysfunction by mechanisms involving oxidative stress.
22. 22 Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis 1998; 141:1-15. This article evaluates recent evidence addressing the pathways that promote LDL oxidation in vivo and the impact this has on the process of atherogenesis.
23. 23 Kirchmair R, Ebenbechler CF, Patsch JR. Post-prandial lipaemia. Bailliere's Clin Endocrinol Metabol. Betteridge DJ (editor). London: Balliere Tindall 1995; 9:705-715.
24. 24 Lewis GF, O'Mera P, Soltys JD, Blackman P, Iverius H, Pugh WL, et al. Fasting hypertriglyceridaemia in non-insulin dependent diabetes mellitus is an important predictor of post-prandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72:934-944.
25. 25 Attaia N, Durlach V, Roche D, Paul JL, Soni T, Zahouni A, et al. Post-prandial metabolism of triglyceride rich lipoproteins in non-insulin dependent diabetic patients before and after bezafibrate treatment. Eur J Clin Invest 1997; 27:55-63.
26. 26 Evans LM, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, Frenneaux MP, Rees A. Post-prandial lipaemia with the production of triglyceride rich lipoproteins results in enhanced oxidative stress and deterioration in endothelial function in non insulin dependent diabetes. Atherosclerosis 1998; 141:186.
27. 27 Garg A. Insulin resistance in the pathogenesis of dyslipidaemia. Diabetes Care 1996; 4:387-389.
28. 28 Demant T, Packard CJ. In vivo studies of VLDL metabolism and LDL heterogeneity. Eur Heart J 1998; 19 (Suppl H): H7-H10.
29. 29 Grenholdt MLN, Nordestgard BG, Wiebee BM, Wilhjelm JE, Sillesen H. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride rich lipoproteins as well as increased plaque content. Circulation 1998; 97:34-40.
30. 30 Gianturco SH, Bradley WA, Gotto AM. Hypertriglyceridaemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest 1982; 70:168-178.
31. 31 Chung BH, Segrest JP. Cytotoxicity of remnants of triglyceride rich lipoproteins: an atherogenic insult? Adv Exp Med Biol 1991; 285:341-351.
32. 32 Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, et al. Triglyceride rich lipoproteins isolated by selected affinity anti apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1994; 14:1767-1774.
33. 33 Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A. HDL and alimentary lipaemia. Studies in men with myocardial infarction at young age. Arterioscler Thromb 1993; 13:11-22.
34. 34 Karpe F, Steiner G, Uffelman K, Olivecronna T, Hamsten A. Post-prandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106:83-97.
35. 35 Patsch JR, Meisenbock G, Hopferweiser T, Muhlberger V, Knapp E, Dunn JK. Relation of triglyceride metabolism and coronary artery disease. Studies in the post-prandial state. Arterioscler Thromb 1993; 12:1336-1345.
36. 36 Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis M, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995; 92:3212-3219.
37. 37 Mergener GW, Weglicki WB, Kramer JH. Post-ischaemic free radical production in the venous blood of the regionally ischaemic swine heart. Circulation 1991; 84:2079-2090.
38. 38 Evans LM, Anderson RA, Ellis GR, Davies JS, Lewis MJ, Frenneaux MP, Rees A. Post-prandial lipaemia, endothelial function and oxidative stress before and after ciprofibrate therapy. Proc British Atherosclerosis Society 1999:(in press).
39. 39 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 327:524-526.
40. 40 O'Driscoll G, Green D, Taylor RR. Simvastatin, a HMG-CoA reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95:1126-1131.
41. 41 Kamata K, Sugiura M, Kojima S, Kasuya Y. Restoration of endothelium dependent relaxation in both hypercholesterolaemia and diabetes by chronic taurine. Eur J Pharmacol 1996; 303:47-53.
42. 42 Palmer AM, Gopaul N, Dhir S, Thomas CR, Poston L, Tribe RM. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by probucol or simvastatin supplementation. Diabetologia 1998; 41:157-164.
43. 43 O'Hara Y, Peterson TE, Harrison DG. Hypercholesterolaemia increases endothelial superoxide anion production. J Clin Invest 1993; 91:1057-1062.
44. 44 Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolaemic patients. Am Heart J 1996; 1051-1057.
45. 45 Gilligan DM, Sack MN, Guetta V. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilatation in patients with hypercholesterolaemia. J Am Coll Cardiol 1994; 24:1611-1617.
46. 46 Wolff SP. Diabetes mellitus. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. BMJ 1993; 49:642-652.
47. 47 Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19:257-267.
48. 48 Plotnick GD, Correti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium dependent brachial artery vasoactivity following a single high fat meal. JAMA 1997; 278:1682-1686.
49. 49 Spiedel MT, Booyse FM, Abrams A, Moore MA, Chung BH. Lipolysed hypertryglyceridaemic serum and triglyceride rich lipoprotein cause lipid accumulation in, and are cytotoxic to, cultured human endothelial cells. High density lipoprotein inhibit this cytotoxicity. Thrombosis Res 1990; 58:251-264.
50. 50 Henning B, Chung BH, Watkins BA, Alvardo A. Disruption of endothelial endothelial barrier function by lipolytic remnants of triglyceride rich lipoproteins. Atherosclerosis 1992; 95:235-247.
51. 51 Nordestgard BG, Wooton R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidaemic rabbits in vivo. Arterioscler Thromb Vasc Biol 1995; 15:534-542.
52. 52 Libby P. Atheroma: more than mush. Lancet 1996; 348:S4-S7.
53. 53 Steiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor 1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10:1067-1073.
54. 54 Levine GN, Keaney JF, Vita JA. Cholesterol reduction and cardiovascular disease. New Engl J Med 1996; 332:512-551.
55. 55 Proani L, Hiramatsu K, Saiusa Y, Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridaemics with and without diabetes. Atherosclerosis 1991; 90:39-47.
56. 56 Armstrong AM, Chestnutt JE, Gromley MJ, Young IS. The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed non-insulin dependent diabetes. Free Rad Biol Med 1996; 21:719-726.
57. 57 Watts GW, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998; 141:17-30. Atherosclerotic vascular disease is a well-recognized association of non-insulin dependent diabetes mellitus (NIDDM). Endothelial dysfunction is a key event in the process of atherogenesis and its occurrence in NIDDM is well described. This article reviews the potential mechanisms by which the dyslipidaemia of NIDDM in association with enhanced oxidative stress may cause endothelial dysfunction.
58. 58 O'Brien SFO, Watts GF, Playford DA, Burke V, O'Neil DN, Best JD. Low-density lipoprotein size, high-density lipoprotein concentration and endothelial cell dysfunction in non-insulin dependent diabetes. Diabetic Med 1997; 14:974-978.